| Experts estimate that one out of every three people suffer from some form of a sleep disorder. Many of these people suffer needlessly simply because they are unaware that a problem exists. |
ROBERT B. SCHADER, M.D., F,C,C.P. RESEARCH EXPERIENCE:
Principal Investigator, Sepracor, Insomnia Secondary to Perimenopause. 2004
Sub - Investigator, Aventis, Primary Insomnia, 2004.
Sub - Investigator, Sepracor, Primary Insonmia, 2004.
Sub - Investigator, Wyeth, Diabetic Neuropathy, 2004.
Sub -. Investigator, Boehringer Ingetheim, Restless Leg Syndrome, 2004.
Sub - Investigator, Sanofi, Chronic Primary Insomnia, 2004.
Sub - Investigator, Cephalon, Primary Insomnia, 2004.
Sub - Investigator. Cephalon, Geriatric Insomnia, 2004.
Sub - Investigator, Somaxon, Primary Sleep Maintenance Insomnia, 2004.
Sub - Investigator, Sanofi, Primary Insomnia, 2003.
Sub - Investigator, Neurocrine Biosciences, Elderly Insomnia, 2003. Sub - Investigator, GlaxoSmithKline, Restless Legs Syndrome, 2003. Sub - Investigator, Nuerocrine Biosciences, Transient Insomnia. 2003. Sub - Investigator, Endo, Chronic Pain, 2003. Sub - Investigator, Endo, Diabetic Peripheral Neuropathy, 2002. Sub - Investigator, GlaxoSmithKline, Restless Legs Syndrome. 2002. Sub - Investigator, Sanofi, Primary Insomnia, 2002. Sub - Investigator, Cephalon, Shift Work Sleep Disorder, 2002. Sub - Investigator, Forest Laboratories, Alzheimer's Disease, 2002. Sub - Investigator, Takeda, Transient Insonmia, 2002. Sub - Investigator, Takeda, Geriatric Insomnia, 2002. Sub - Investigator, Takeda, Elderly Chronic Insomnia, 2002. Sub - Investigator, Neurocrnie Biosciences, Primary Insomnia, 2002. Sub - Investigator, Neurocrine Biosciences, Elderly Insomnia, 2002. Sub - Investigator, GlaxoSmithKline, Restless Legs Syndrome, 2001. Sub - Investigator, Novartis, Neuropathic Pain, 2002. Sub - Investigator, Sepracor, Elderly Primary Insomnia, 2001. Sub - Investigator, Takeda, Chronic Insomnia, 2002. Sub - Investigator, Forest Laboratories, Alzheimer's Disease, 2001. Sub - Investigator, Janssen, Cerebrovascular Disease, 2001. Sub - Investigator, Sepracor, Primary Insomnia, 2001. Sub - Investigator, Neotherapeutics, Alzlieimer's Disease, 2001 Sub-Investigator: A Double-blind, Randomized, Placebo-Controlled Surveillance Study of Asthma Event Outcomes in Subjects Receiving Either Usual Pharmacotherapy of Asthma or Usual Pharmacotherapy Plus Salmeterol 42 mcg (2 puffs) twice daily. (Version: 3/28/96) Asthma Research Associate), 1996. Sub-Investigator: A prospective, randomized, comparative study of ciprofloxacin and clarithromycin for the treatment of acute bacterial exacerbations of chronic bronchitis. Therapeutic Management, 1996. Principal Investigator: GNE Z0610g - A Multinational, Multicenter, Double blind, Placebo-controlled Phase III Study to evaluate the safety arid efficacy of aerosolized recombinant human DNase I in hospitalized patients with chronic obstructive pulmonary disease experiencing a pulmonary exacerbation/Genentech, Inc. Research, 1995. Principal Investigator: Levofloxacin in the treatment of adults with comnumit-y acquired pneumonia, 1994. Principal Investigator: Levofloxacin in the treatment of adults with bronchitis who also have COPD, 1994. Principal Investigator: Ofloxacin in the treatment of adults with nosocomial pneumonia, 1994. |
